Search Terms
Call us today 212-583-0100
ir@enzo.com
Toggle navigation
Home
Corporate
Investor Information
About Us
Officers & Directors
Press Releases
Careers
Therapeutics
About ENZO Therapeutics
Overview
Our Mission
Our Strategy
Partnering
Maps and Directions
Contact Us
Therapeutic Market
Overview
Inflammatory Bowel Disease
Uveitis
HIV
Bone Disorders
Diabetes
Technologies
Immune Regulation
Gene Technology
Cell Signaling Modulation
Pipeline
Overview
Cell Signaling Modulation
Diabetes
Preclinical Studies for Bone Disorders
Immune Regulation
Alequel ™
Optiquel ™
Gene Technology
Stealth Vector™ HGTV43™
Clinical Labs
Life Sciences
Contact
IR Calendar
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Governance Documents
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
2024 Annual Meeting of Shareholders
Jan 15, 2025 9:00 am EST
Audio
Webcast
Email Alerts
Tear Sheet
Contacts
RSS News Feed